HUP9903688A2 - Olanzapin alkalmazása az autizmus kezelésére szolgáló gyógyszerkészítmény előállítására - Google Patents
Olanzapin alkalmazása az autizmus kezelésére szolgáló gyógyszerkészítmény előállításáraInfo
- Publication number
- HUP9903688A2 HUP9903688A2 HU9903688A HUP9903688A HUP9903688A2 HU P9903688 A2 HUP9903688 A2 HU P9903688A2 HU 9903688 A HU9903688 A HU 9903688A HU P9903688 A HUP9903688 A HU P9903688A HU P9903688 A2 HUP9903688 A2 HU P9903688A2
- Authority
- HU
- Hungary
- Prior art keywords
- olanzapine
- preparation
- pharmaceutical compositions
- treating autism
- compositions treating
- Prior art date
Links
- 208000020706 Autistic disease Diseases 0.000 title abstract 2
- KVWDHTXUZHCGIO-UHFFFAOYSA-N olanzapine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C=C(C)S2 KVWDHTXUZHCGIO-UHFFFAOYSA-N 0.000 title abstract 2
- 229960005017 olanzapine Drugs 0.000 title abstract 2
- 206010003805 Autism Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000036626 Mental retardation Diseases 0.000 abstract 1
- ZCDOYSPFYFSLEW-UHFFFAOYSA-N chromate(2-) Chemical compound [O-][Cr]([O-])(=O)=O ZCDOYSPFYFSLEW-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Chemical Treatment Of Metals (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Luminescent Compositions (AREA)
- Control Of Motors That Do Not Use Commutators (AREA)
- Transplanting Machines (AREA)
Abstract
A találmány eljárást nyújt az aűtisztikűs betegség és/vagy a szellemielmaradőttság kezelésére, ami abból áll, hőgy a kezelésre szőrűlóbeteg szervezetébe őlanzapinnak vagy gyógyászati szempőntbólalkalmazható sójának vagy szőlvátjának hatásős mennyiségét jűttatjákbe. ŕ
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1316296P | 1996-03-11 | 1996-03-11 | |
PCT/US1996/019576 WO1997033585A1 (en) | 1996-03-11 | 1996-12-04 | Method for treating autism |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9903688A2 true HUP9903688A2 (hu) | 2000-03-28 |
HUP9903688A3 HUP9903688A3 (en) | 2001-12-28 |
Family
ID=21758619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9903688A HUP9903688A3 (en) | 1996-03-11 | 1996-12-04 | Use of olanzapine for the preparation of pharmaceutical compositions treating autism |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0946179B1 (hu) |
JP (1) | JP2000506860A (hu) |
KR (1) | KR19990087715A (hu) |
CN (1) | CN1213970A (hu) |
AT (1) | ATE249832T1 (hu) |
AU (1) | AU709181B2 (hu) |
BR (1) | BR9612552A (hu) |
CA (1) | CA2248741A1 (hu) |
CZ (1) | CZ290498A3 (hu) |
DE (1) | DE69630055T2 (hu) |
EA (1) | EA000768B1 (hu) |
ES (1) | ES2206614T3 (hu) |
HU (1) | HUP9903688A3 (hu) |
IL (1) | IL126161A0 (hu) |
NO (1) | NO984197L (hu) |
NZ (1) | NZ324615A (hu) |
PL (1) | PL328948A1 (hu) |
TR (1) | TR199801798T2 (hu) |
WO (1) | WO1997033585A1 (hu) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002530339A (ja) | 1998-11-23 | 2002-09-17 | セプラコール, インク. | 2−ヒドロキシメチルオランザピン組成物及び方法 |
JP2002530341A (ja) * | 1998-11-23 | 2002-09-17 | セプラコール, インク. | デスメチルオランザピン組成物及び方法 |
ATE253364T1 (de) * | 1998-11-23 | 2003-11-15 | Sepracor Inc | Olanzapin-n-oxide enthaltende pharmaceutische zusammensetzungen |
WO2014018468A1 (en) | 2012-07-22 | 2014-01-30 | Indiana University Research And Technology Corporation | Modulation sapp, sapp alpha and bdnf levels in individuals diagnosed with fxs and asd |
PT3058371T (pt) | 2013-10-14 | 2021-07-26 | Univ Indiana Res & Tech Corp | Uso de acamprosato para modular a ativação de erk 1-2 em modelos animais de sxf e tea e indivíduos diagnosticados com sxf e tea |
RU2666598C1 (ru) * | 2017-07-14 | 2018-09-11 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" | Средство для коррекции расстройств аутистического спектра |
KR102285577B1 (ko) | 2020-11-11 | 2021-08-04 | 김의철 | 자폐를 가진 유소년의 무약물 치료방법 및 시스템 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225407A (en) * | 1990-02-22 | 1993-07-06 | Glaxo Group Limited | 5-HT3 receptor antagonists for the treatment of autism |
US5229382A (en) * | 1990-04-25 | 1993-07-20 | Lilly Industries Limited | 2-methyl-thieno-benzodiazepine |
US5457101A (en) * | 1994-06-03 | 1995-10-10 | Eli Lilly And Company | Thieno[1,5]benzoidiazepine use |
-
1996
- 1996-12-04 BR BR9612552A patent/BR9612552A/pt not_active Application Discontinuation
- 1996-12-04 IL IL12616196A patent/IL126161A0/xx unknown
- 1996-12-04 ES ES96942934T patent/ES2206614T3/es not_active Expired - Lifetime
- 1996-12-04 KR KR1019980707182A patent/KR19990087715A/ko not_active Application Discontinuation
- 1996-12-04 TR TR1998/01798T patent/TR199801798T2/xx unknown
- 1996-12-04 DE DE69630055T patent/DE69630055T2/de not_active Expired - Fee Related
- 1996-12-04 JP JP09532571A patent/JP2000506860A/ja not_active Withdrawn
- 1996-12-04 AT AT96942934T patent/ATE249832T1/de not_active IP Right Cessation
- 1996-12-04 CA CA002248741A patent/CA2248741A1/en not_active Abandoned
- 1996-12-04 EA EA199800821A patent/EA000768B1/ru not_active IP Right Cessation
- 1996-12-04 NZ NZ324615A patent/NZ324615A/xx unknown
- 1996-12-04 PL PL96328948A patent/PL328948A1/xx unknown
- 1996-12-04 CN CN96180207A patent/CN1213970A/zh active Pending
- 1996-12-04 WO PCT/US1996/019576 patent/WO1997033585A1/en active IP Right Grant
- 1996-12-04 CZ CZ982904A patent/CZ290498A3/cs unknown
- 1996-12-04 EP EP96942934A patent/EP0946179B1/en not_active Expired - Lifetime
- 1996-12-04 HU HU9903688A patent/HUP9903688A3/hu unknown
- 1996-12-04 AU AU11501/97A patent/AU709181B2/en not_active Ceased
-
1998
- 1998-09-11 NO NO984197A patent/NO984197L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE69630055T2 (de) | 2004-06-03 |
CN1213970A (zh) | 1999-04-14 |
WO1997033585A1 (en) | 1997-09-18 |
KR19990087715A (ko) | 1999-12-27 |
CZ290498A3 (cs) | 1999-10-13 |
EA000768B1 (ru) | 2000-04-24 |
BR9612552A (pt) | 1999-07-20 |
EP0946179A4 (en) | 2000-04-19 |
PL328948A1 (en) | 1999-03-01 |
TR199801798T2 (xx) | 1998-12-21 |
NZ324615A (en) | 2000-08-25 |
CA2248741A1 (en) | 1997-09-18 |
JP2000506860A (ja) | 2000-06-06 |
ES2206614T3 (es) | 2004-05-16 |
NO984197D0 (no) | 1998-09-11 |
EA199800821A1 (ru) | 1999-02-25 |
AU1150197A (en) | 1997-10-01 |
EP0946179B1 (en) | 2003-09-17 |
DE69630055D1 (de) | 2003-10-23 |
AU709181B2 (en) | 1999-08-26 |
HUP9903688A3 (en) | 2001-12-28 |
ATE249832T1 (de) | 2003-10-15 |
NO984197L (no) | 1998-11-03 |
IL126161A0 (en) | 1999-05-09 |
EP0946179A1 (en) | 1999-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE59009462D1 (de) | Implantierbare Vorrichtung zur dosierten Abgabe von Medikamenten in den menschlichen Körper. | |
NZ504026A (en) | Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C | |
BR0209365A (pt) | Usos farmacêuticos de bisfosfonatos | |
DE69535349D1 (de) | Implantierbare aktive medizinische Vorrichtung mit Mittel zur Unterscheidung zwischen Ruhe- bzw. Aktivzustand des Patienten | |
HUP0302114A2 (hu) | Eritropoietin-fehérjét tartalmazó folyékony gyógyászati készítmény, eljárás előállítására és alkalmazása | |
HUP9904023A2 (hu) | Leptin antagonisták alkalmazása inzulin rezisztencia kezelésére II. típusú cukorbajban | |
BR9709915A (pt) | Composto composição farmacêutica utilização do composto e processos para o tratamento ou a prevençao de distúrbios fisiológicos asociados com um excesso de taquiquininas e para preparação do composto | |
ES2138729T3 (es) | Metodos de diagnostico de la preeclampsia. | |
ATE91628T1 (de) | Sauerwiderstehender fibroblast-wachstumsfaktor, zubereitung zur behandlung von magen-darmweggeschw¨rkrankheiten. | |
HUP0401867A2 (hu) | A valproinsav-amid és a 2-valproénsav-amid származékainak használata a fájdalommal és a fejfájással járó betegségek kezelésére vagy megelőzésére | |
DE69116380D1 (de) | Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit | |
KR950700726A (ko) | 치료 또는 진단용 조성물, 그 제조방법 및 용도(composition for therapeutic or diagnostic use, process for its preparation and its use) | |
HUP9903688A2 (hu) | Olanzapin alkalmazása az autizmus kezelésére szolgáló gyógyszerkészítmény előállítására | |
WO1999056666A8 (en) | The treatment of sexual dysfunction in certain patient groups | |
KR100488038B1 (ko) | 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도 | |
HUP9903679A2 (hu) | Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására | |
ATE78168T1 (de) | Arzneimittelzusammensetzung zur vorbeugung und behandlung bakterieller und viraler krankheiten. | |
HUP9903685A2 (hu) | Olanzapin alkalmazása túlzott agresszivitás kezelésére szolgáló gyógyszerkészítmények előállítására | |
TR199801801T2 (xx) | Madde k�t�ye kullan�m�n�n tedavisi. | |
DE3765916D1 (de) | Sonde zur einfuehrung in den verdauungs- oder ausscheidungstrakt des menschlichen oder tierischen koerpers, insbesondere lithotriptor-sonde. | |
FR2818147B1 (fr) | Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine | |
ID28817A (id) | Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri | |
ATE57841T1 (de) | Sonde zur einfuehrung in den verdauungs- oder ausscheidungstrakt des menschlichen oder tierischen koerpers, insbesondere lithotriptorsonde. | |
UA19596A (uk) | Спосіб лікуваhhя гіпертоhічhої хвороби гірудорефлексотерапією | |
WO1994016103A3 (en) | Detection of synthetic oligonucleotides extracted from body fluids or tissues |